دورية أكاديمية
أعرض في EDS

Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.

التفاصيل البيبلوغرافية
العنوان: Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.
المؤلفون: Miner CA; Department of Community Medicine, College of Health Sciences, University of Jos, Jos, Plateau State, Nigeria., Timothy CG; Department of Optometry, Mzuzu University, Mzuzu, Malawi., Percy K, Mashige; African Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa., Osuagwu UL; African Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. l.osuagwu@westernsydney.edu.au.; Bathurst Rural Clinical School, School of Medicine, Western Sydney University, Bathurst, NSW, 2795, Australia. l.osuagwu@westernsydney.edu.au.; Translational Health Research Institute (THRI), Western Sydney University, 2506, New South Wales, Australia. l.osuagwu@westernsydney.edu.au., Envuladu EA; Department of Community Medicine, College of Health Sciences, University of Jos, Jos, Nigeria., Amiebenomo OM; School of Optometry and Vision Sciences, College of Biomedical Sciences, Cardiff University, Cardiff, UK.; Department of Optometry, Faculty of Life Sciences, University of Benin, Benin City, Ugbowo, Nigeria., Ovenseri-Ogbomo G; African Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.; Department of Optometry, Centre for Health Sciences, University of the Highlands and Islands, Inverness, UK., Charwe DD; Tanzania Food and Nutrition Center, Dar-Es-Salaam, Tanzania., Goson PC; Department of Psychiatry, College of Health Sciences, University of Jos, Jos, Plateau State, Nigeria., Ekpenyong BN; African Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.; Department of Public Health, Faculty of Allied Medical Sciences, College of Medical Sciences, University of Calabar, Cross River State, Calabar, Nigeria., Abu EK; Department of Optometry and Vision Science, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana., Langsi R; Health Division, University of Bamenda, Bambili, Cameroon., Oloruntoba R; School of Management and Marketing, Curtin University, Kent Street, Bentley, WA, 6102, Australia., Ishaya T; Department of Computer Science, University of Jos, Jos, Nigeria., Agho KE; African Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.; Translational Health Research Institute (THRI), Western Sydney University, 2506, New South Wales, Australia.; School of Health Science, Western Sydney University, Campbelltown, Australia.
المصدر: BMC public health [BMC Public Health] 2023 Jan 28; Vol. 23 (1), pp. 191. Date of Electronic Publication: 2023 Jan 28.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control , Vaccines*, Humans ; COVID-19 Vaccines ; African People ; Cross-Sectional Studies ; Probability ; Vaccination
مستخلص: Background: The COVID-19 vaccines are being rolled out across all the sub-Saharan Africa (SSA) countries, with countries setting targets for achieving full vaccination rates. The aim of this study was to compare the uptake of, resistance and hesitancy to the COVID-19 vaccine between SSA locally residents and in the diasporan dwellers.
Methods: This was a cross-sectional study conducted using a web and paper-based questionnaire to obtain relevant information on COVID-19 vaccine acceptance. The survey items included questions on demography, uptake and planned acceptance or non-acceptance of the COVID-19 vaccines among SSAs. Multinomial logistic regression was used to determine probabilities of outcomes for factors associated with COVID-19 vaccination resistance and hesitancy among SSA respondents residing within and outside Africa.
Results: Uptake of COVID-19 vaccines varied among the local (14.2%) and diasporan (25.3%) dwellers. There were more locals (68.1%) who were resistant to COVID-19 vaccine. Participants' sex [adjusted relative risk (ARR) = 0.73, 95% CI: 0.58 - 0.93], education [primary/less: ARR = 0.22, CI:0.12 - 0.40, and bachelor's degree: ARR = 0.58, CI: 0.43 - 0.77]), occupation [ARR = 0.32, CI: 0.25-0.40] and working status [ARR = 1.40, CI: 1.06-1.84] were associated with COVID-19 vaccine resistance among locals. Similar proportion of local and diasporan dwellers (~ 18% each) were hesitant to COVID-19 vaccine, and this was higher among health care workers [ARR = 0.25, CI: 0.10 - 0.62 and ARR = 0.24, CI:0.18-0.32, diaspora and locals respectively]. After adjusting for the potential confounders, local residents aged 29-38 years [ARR = 1.89, CI: 1.26-2.84] and lived in East Africa [ARR = 4.64, CI: 1.84-11.70] were more likely to report vaccine hesitancy. Knowledge of COVID vaccines was associated with hesitancy among local and diasporan dwellers, but perception was associated with vaccine resistance [ARR = 0.86,CI: 0.82 - 0.90] and hesitancy [ARR = 0.85, CI: 0.80 - 0.90], only among the local residents.
Conclusions: Differences exist in the factors that influence COVID-19 vaccine acceptance between local SSA residents and thediasporan dwellers. Knowledge about COVID-19 vaccines affects the uptake, resistance, and hesitancy to the COVID-19 vaccine. Information campaigns focusing on the efficacy and safety of vaccines could lead to improved acceptance of COVID-19 vaccines.
(© 2023. The Author(s).)
References: Proc Natl Acad Sci U S A. 2021 Dec 7;118(49):. (PMID: 34795017)
Int J Infect Dis. 2021 Mar;104:742-745. (PMID: 33556610)
JAMA Netw Open. 2021 Aug 02;4(8):e2121931. (PMID: 34459907)
J Health Commun. 2020 Oct 2;25(10):799-807. (PMID: 33719881)
Vaccine. 2020 Jan 29;38(5):1160-1169. (PMID: 31791811)
Risk Manag Healthc Policy. 2021 Jun 21;14:2609-2623. (PMID: 34188572)
Niger Postgrad Med J. 2020 Oct-Dec;27(4):261-267. (PMID: 33154276)
PLoS One. 2021 Sep 3;16(9):e0257109. (PMID: 34478470)
Pediatr Nurs. 2005 Sep-Oct;31(5):380-6. (PMID: 16295153)
Pan Afr Med J. 2021 Sep 03;40:10. (PMID: 34650660)
BMC Public Health. 2021 Aug 18;21(1):1562. (PMID: 34404377)
J Public Health (Oxf). 2018 Mar 1;40(1):121-128. (PMID: 28369548)
Vaccines (Basel). 2021 Mar 12;9(3):. (PMID: 33809002)
Brain Behav Immun. 2021 May;94:41-50. (PMID: 33713824)
J Gen Intern Med. 2021 Jul;36(7):2130-2133. (PMID: 33754319)
Am J Infect Control. 2022 Jan;50(1):20-25. (PMID: 34653527)
Cureus. 2021 Sep 15;13(9):e17990. (PMID: 34667668)
Euro Surveill. 2021 Dec;26(50):. (PMID: 34915975)
Health Secur. 2021 Jan-Feb;19(1):44-56. (PMID: 33606572)
EClinicalMedicine. 2020 Sep;26:100495. (PMID: 32838242)
PLoS One. 2021 Apr 23;16(4):e0250555. (PMID: 33891660)
J Relig Health. 2021 Feb;60(1):65-80. (PMID: 33125543)
Vaccine. 2022 Jan 3;40(1):151-161. (PMID: 34863621)
J Med Virol. 2022 Apr;94(4):1738-1744. (PMID: 34905235)
JAMA. 2022 Feb 8;327(6):583-584. (PMID: 34967859)
Vaccines (Basel). 2022 Feb 10;10(2):. (PMID: 35214724)
Vaccine. 2022 Mar 8;40(11):1643-1654. (PMID: 33933316)
J Med Internet Res. 2020 Apr 2;22(4):e18790. (PMID: 32240094)
Hum Vaccin Immunother. 2021 May 4;17(5):1304-1312. (PMID: 33118868)
BMJ Open. 2018 May 17;8(5):e021006. (PMID: 29773702)
J Community Health. 2021 Apr;46(2):270-277. (PMID: 33389421)
Lancet. 2021 Apr 3;397(10281):1265-1275. (PMID: 33773118)
BMJ. 2021 May 20;373:n1138. (PMID: 34016653)
PLoS One. 2021 Nov 29;16(11):e0260672. (PMID: 34843594)
Vaccines (Basel). 2021 Sep 24;9(10):. (PMID: 34696172)
Front Microbiol. 2020 Mar 17;11:372. (PMID: 32256465)
Int J Health Plann Manage. 2021 Jul;36(4):1178-1188. (PMID: 33819370)
Procedia Vaccinol. 2011;5:127-136. (PMID: 32288915)
Int J MCH AIDS. 2021;10(1):134-138. (PMID: 33868778)
Clin Infect Dis. 2022 Sep 14;75(5):893-896. (PMID: 35134167)
Lancet Microbe. 2021 Jul;2(7):e279-e280. (PMID: 33899038)
JAMA Netw Open. 2021 Sep 1;4(9):e2126882. (PMID: 34559232)
PLoS One. 2021 Dec 1;16(12):e0260575. (PMID: 34851998)
Biomed J. 2020 Aug;43(4):328-333. (PMID: 32387617)
PLoS One. 2021 Dec 21;16(12):e0260731. (PMID: 34932583)
Viruses. 2022 Jan 30;14(2):. (PMID: 35215887)
فهرسة مساهمة: Keywords: Acceptance; COVID-19; Diaspora; Hesitancy; Locals; Resistance; Sub-Sahara Africa; Vaccination
المشرفين على المادة: 0 (COVID-19 Vaccines)
0 (Vaccines)
تواريخ الأحداث: Date Created: 20230128 Date Completed: 20230131 Latest Revision: 20230210
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9884132
DOI: 10.1186/s12889-023-15116-w
PMID: 36709269
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2458
DOI:10.1186/s12889-023-15116-w